The map of cystic fibrosis (CF) research is being redrawn in the U.K. as improvements in treatment, and in particular the introduction of CF modulator drugs, mean people with the rare inherited ...
In a flurry of news releases on Feb. 27, Teleflex Inc. reported plans to buy the vascular intervention business of Biotronik ...
Whole genome sequencing has substantially accelerated the pace of discovery of genes that cause rare diseases, but while this ...
Patients with metastatic or unresectable gastric cancer are usually given 5-fluorouracil (5-FU) and platinum-based chemotherapy, but patients with advance disease usually have a poor prognosis. The ...
The FDA’s final rule for lab-developed tests (LDTs) is in litigation, and a district court decision may be shortly in the ...
Scientists at the University of Aberdeen developed a new scanner that distinguishes breast tumor material from healthy tissue ...
The routine use of software to interpret the results of lab-developed tests (LDTs) leaves clinical labs in a complicated spot in 2025 thanks in no small part to an ongoing lawsuit over the U.S. FDA’s ...
After a second round, the U.S. FDA has accepted for review radiopharmaceutical company Telix Pharmaceuticals Ltd.’s BLA for ...
A panel at Biocom California’s 15th Annual Global Life Science Partnering & Investor Conference covered the emerging use of ...
Researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Miramoon Pharma ...
Reflecting a positive reception in the market, Kestra Medical Technologies Ltd. increased the target haul for its planned IPO ...
In general, tumor cells embody the idea of “the survival of the fittest” gone out of control. Tumor cells outcompete their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results